Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 5/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL348089 | 0.79 | CYP3A4 (0.62) | CYP3A4MAPK1TDP1AHRCYP2A6 | |
| Methane SCHEMBL23466796 | 0.75 | CYP3A4 (0.59) | CYP3A4MAPK1TDP1AHRCYP2A6 | |
| SCHEMBL5961683 | 0.75 | CES1 (0.36) | CES1LMNA | |
| SCHEMBL329345 | 0.73 | — | — | |
| SCHEMBL714058 | 0.71 | CYP3A4 (0.41) | CYP3A4MAPK1TDP1AHRCYP2A6 | |
| Benzene SCHEMBL186559 | 0.69 | CYP3A4 (0.53) | CYP3A4MAPK1TDP1AHRCYP2A6 | |
| SCHEMBL10925713 | 0.69 | ALDH1A1 (0.44) | MAPK1MEN1KMT2ATSHRLMNA | |
| SCHEMBL9594463 | 0.69 | NOTUM (0.33) | MAPK1MEN1KMT2ANOTUM | |
| SCHEMBL9819330 | 0.69 | CYP3A4 (0.59) | CYP3A4MAPK1AHRTSHR | |
| SCHEMBL9595483 | 0.68 | SLC2A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118146226-A | Pyrrolo [2,3-d ] pyrimidine compound with nitrogen-containing heterocyclic structure, and preparation method and application thereof | 贵州大学 | 2024-06-07 | — | — | CN | claimed |
| CN-118084865-A | Pyrimidine compound containing aminopiperidine structure, and preparation method and application thereof | 贵州大学 | 2024-05-28 | — | — | CN | claimed |
| US-11779663-B2 | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-10-10 | — | — | US | claimed |
| US-20230241241-A1 | CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-08-03 | — | — | US | claimed |
| CN-116143678-A | Conjugate linker, cell-binding molecule-drug conjugate containing the same, and preparation and application thereof | 杭州多禧生物科技有限公司 | 2023-05-23 | — | — | CN | claimed |
| EP-4168009-A1 | CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS | Hangzhou DAC Biotech Co., Ltd. (CN) | 2023-04-26 | — | — | EP | claimed |
| US-20230071112-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-03-09 | — | — | US | claimed |
| US-11591275-B2 | Smart release potash fertilizer granules | RYNAN TECHNOLOGIES PTE LTD (SG) | 2023-02-28 | — | — | US | claimed |
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-01-12 | — | — | US | claimed |
| US-20230001001-A1 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-01-05 | — | — | US | claimed |
| JP-2012500804-A | — | — | 2012-01-12 | — | — | JP | claimed |
| EP-2328619-A2 | POLYMERIC BENZYL CARBONATE-DERIVATIVES | Baxter International Inc. (US) | 2011-06-08 | — | — | EP | claimed |
| CN-101877966-A | Farnesoid X receptor agonists | SMITHKLINE BEECHAM CORP | 2010-11-03 | — | — | CN | claimed |
| US-20100048483-A1 | POLYMERIC BENZYL CARBONATE-DERIVATIVES | BAXTER HEALTHCARE S.A. (CH) | 2010-02-25 | — | — | US | claimed |
| WO-2010022320-A2 | POLYMERIC BENZYL CARBONATE-DERIVATIVES | BAXTER INTERNATIONAL INC. (US) | 2010-02-25 | — | — | WO | claimed |
| CN-1018825-B | Process for preparing poly-4-aminopyrrole-2-carboxamido derivatives | ERBA FARMITALIA (IT) | 1992-10-28 | — | — | CN | claimed |
| EP-0209487-B1 | PREPARATION OF COPPER PHTHALOCYANINE IN A PIGMENTARY FORM | CIBA-GEIGY AG (CH) | 1992-08-05 | — | — | EP | claimed |
| US-4801634-A | TRICHLOROPHENOXY COPPER PHTHALOCYANINE, RUBBER OR PLASTIC | CIBA-GEIGY CORPORATION (US) | 1989-01-31 | — | — | US | claimed |
| US-4801638-A | TRICHLOROPHENOXY COPPER PHTHALOCYANINE, PAINT OR INK | CIBA-GEIGY CORPORATION (US) | 1989-01-31 | — | — | US | claimed |
| US-4694078-A | HEAT STABLE | CIBA-GEIGY CORPORATION (US) | 1987-09-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230001001-A1 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | CD4, MCL1, CCNB1 | CYP3A4 1679/4885MAPK1 1789/4885TDP1 1199/4885 |
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | DAO, DDO, DCLRE1A | CYP3A4 2182/4885MAPK1 4194/4885TDP1 2253/4885 |
| US-20100048483-A1 | POLYMERIC BENZYL CARBONATE-DERIVATIVES | SI, SLC1A5, BCAT1 | CYP3A4 302/4885MAPK1 4501/4885TDP1 3674/4885 |
| US-11779663-B2 | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | SLC25A1, GCDH, FH | CYP3A4 2674/4885MAPK1 4550/4885TDP1 3693/4885 |
| US-20230241241-A1 | CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS | CD4, DCLRE1A, TOP1 | CYP3A4 4501/4885MAPK1 3987/4885TDP1 878/4885 |
| US-20230071112-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | CD2BP2, DCLRE1A, EPCAM | CYP3A4 4282/4885MAPK1 4162/4885TDP1 3362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.